An Author is an individual who has significantly contributed to the development of a manuscript. It is the responsibility of who listed as an author of an article published in Pharma Research to have contributed in a meaningful and identifiable way to the design, performance, analysis, and reporting of the work.
International Committee of Medical Journal Editors (ICMJE) Recommendations recommends that authorship be based on the following four criteria:
Each author must sign a statement attesting that he or she fulfils the authorship criteria before publication. At least one person’s name must accompany a group name.
Pharma Research permits only one corresponding author per manuscript. This person is solely responsible for all correspondence with the Journal and will receive all communication related to the publication process.
Whenever there is a need to make changes in the authorship of a manuscript or a published article, the changes will be implemented according to COPE specification. Only corresponding authors can make request for a change in authorship. Request should be made to the editor using the Changes in Authorship Form.
Authors should read the “Author Guidelines” on the journal’s page before submission. Manuscript should be prepared according to the style and specifications of the journal’s policy. Authors listed on the manuscript should have met the requirements for Authorship specified above. All authors should approve the final version of the manuscript prior to submission. Once a manuscript is submitted, it is therefore assumed that all authors have read and given their approval for the submission of the manuscript.
Contact information of all authors should be stated on the manuscript i.e., affiliation, emails, and phone numbers.
Declaration of Conflicts of Interest should be stated in the manuscript.
Conflict of interest exists when there is a divergence between an individual’s private interests (competing interests) and his or her responsibilities to scientific and publishing activities such that a reasonable observer might wonder if the individual’s behaviour or judgment was motivated by considerations of his or her competing interests” WAME.
Authors should disclose all financial/relevant interest that may have influenced the development of the manuscript.
Reviewers should disclose any conflict of interest and if necessary, decline the review of any manuscript they perceive to have a conflict of interest. Editors should also decline from considering
any manuscript that may have conflict of interest. Such manuscripts will be re-assigned to other editors.
When submitting a manuscript, the authors should affirm that no similar manuscript is or will be under consideration for publication elsewhere.
Pharma Research will not disclose submitted manuscript to anyone. Authors should also treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.
All accepted manuscripts will go through a plagiarism prior to publication. We use plagiarism detection software such as iThenticate and Similarity Check, which is offered through CrossRef and is powered by iThenticate. If a manuscript is accepted for publication, it is screened a second time to ensure there are no instances of plagiarism.
We investigate all instances of alleged scientific misconduct identified in our published papers (including, but not limited to, plagiarism, inappropriate data processing, and duplicate publication). Depending on the outcome of our investigation, we may publish an erratum or corrigendum, or retracting the paper. When necessary, retraction of articles will be done according to COPE retraction guidelines